CBPLPharmaceuticals
Chandra Bhagat Pharma Ltd — Balance Sheet
₹30.50
-4.77%
Chandra Bhagat Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.75 Cr | 0.75 Cr | 0.75 Cr | 0.75 Cr | — |
| Share Issued | 0.75 Cr | 0.75 Cr | 0.75 Cr | 0.75 Cr | — |
| Net Debt | 20.19 Cr | 11.46 Cr | 12.51 Cr | 15.44 Cr | — |
| Total Debt | 20.86 Cr | 16.43 Cr | 18.94 Cr | 21.12 Cr | — |
| Tangible Book Value | 29.97 Cr | 29.01 Cr | 27.48 Cr | 26.68 Cr | — |
| Invested Capital | 50.83 Cr | 45.44 Cr | 46.42 Cr | 47.79 Cr | — |
| Working Capital | 28.20 Cr | 26.86 Cr | 31.14 Cr | 32.67 Cr | — |
| Net Tangible Assets | 29.97 Cr | 29.01 Cr | 27.48 Cr | 26.68 Cr | — |
| Common Stock Equity | 29.97 Cr | 29.01 Cr | 27.48 Cr | 26.68 Cr | — |
| Total Capitalization | 32.25 Cr | 30.42 Cr | 31.41 Cr | 32.10 Cr | — |
| Total Equity Gross Minority Interest | 29.97 Cr | 29.01 Cr | 27.48 Cr | 26.68 Cr | — |
| Stockholders Equity | 29.97 Cr | 29.01 Cr | 27.48 Cr | 26.68 Cr | — |
| Capital Stock | 7.55 Cr | 7.55 Cr | 7.55 Cr | 7.55 Cr | — |
| Common Stock | 7.55 Cr | 7.55 Cr | 7.55 Cr | 7.55 Cr | — |
| Total Liabilities Net Minority Interest | 71.56 Cr | 72.80 Cr | 33.10 Cr | 45.79 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.31 Cr | 1.74 Cr | 6.16 Cr | 7.74 Cr | — |
| Other Non Current Liabilities | 0.03 Cr | 0.15 Cr | 0.29 Cr | 0.39 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 0.01 Cr | 0.01 Cr | — |
| Long Term Debt And Capital Lease Obligation | 2.28 Cr | 1.41 Cr | 3.93 Cr | 5.42 Cr | — |
| Long Term Debt | 2.28 Cr | 1.41 Cr | 3.93 Cr | 5.42 Cr | — |
| Current Liabilities | 69.25 Cr | 71.06 Cr | 26.95 Cr | 38.05 Cr | — |
| Other Current Liabilities | 41.32 Cr | -1000.00 | 0.24 Cr | 0.25 Cr | — |
| Current Debt And Capital Lease Obligation | 18.58 Cr | 15.01 Cr | 15.02 Cr | 15.70 Cr | — |
| Current Debt | 18.58 Cr | 15.01 Cr | 15.02 Cr | 15.70 Cr | — |
| Current Provisions | 0.40 Cr | 0.07 Cr | 0.03 Cr | 0.04 Cr | — |
| Payables | 8.95 Cr | 13.47 Cr | 3.24 Cr | 2.81 Cr | — |
| Accounts Payable | 8.95 Cr | 13.23 Cr | 3.10 Cr | 2.67 Cr | — |
| Total Assets | 101.53 Cr | 101.80 Cr | 60.58 Cr | 72.46 Cr | — |
| Total Non Current Assets | 4.08 Cr | 3.89 Cr | 2.49 Cr | 1.74 Cr | — |
| Other Non Current Assets | 1.39 Cr | 1.34 Cr | 0.96 Cr | -1000.00 | — |
| Non Current Deferred Taxes Assets | 0.07 Cr | 0.02 Cr | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE | 2.62 Cr | 2.52 Cr | 0.73 Cr | 0.47 Cr | — |
| Gross PPE | 2.62 Cr | 3.78 Cr | 1.50 Cr | 1.13 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Properties | 2.62 Cr | 2.52 Cr | 0.73 Cr | 0.47 Cr | — |
| Current Assets | 97.45 Cr | 97.92 Cr | 58.09 Cr | 70.73 Cr | — |
| Other Current Assets | 1.11 Cr | 2000.00 | 1000.00 | 1000.00 | — |
| Inventory | 0.69 Cr | 8.68 Cr | 29.08 Cr | 34.16 Cr | — |
| Other Receivables | 58.90 Cr | 13.83 Cr | 4.94 Cr | 4.20 Cr | — |
| Accounts Receivable | 35.95 Cr | 39.45 Cr | 8.19 Cr | 15.00 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.80 Cr | 5.10 Cr | 6.55 Cr | 5.90 Cr | — |
| Other Short Term Investments | 0.14 Cr | 0.13 Cr | 0.11 Cr | 0.22 Cr | — |
| Cash And Cash Equivalents | 0.67 Cr | 4.96 Cr | 6.44 Cr | 5.68 Cr | — |
| Cash Financial | 0.67 Cr | 4.96 Cr | 6.44 Cr | 5.68 Cr | — |
| Tradeand Other Payables Non Current | — | 0.17 Cr | 1.93 Cr | 1.92 Cr | 3.57 Cr |
| Current Deferred Taxes Liabilities | — | 0.60 Cr | 0.29 Cr | 0.27 Cr | 0.30 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.13 Cr | 0.61 Cr | 0.76 Cr | 1.01 Cr |
| Other Payable | — | 0.03 Cr | 0.02 Cr | 0.03 Cr | 0.72 Cr |
| Total Tax Payable | — | 0.22 Cr | 0.12 Cr | 0.11 Cr | 0.16 Cr |
| Non Current Prepaid Assets | — | 0.69 Cr | 0.81 Cr | — | — |
| Non Current Deferred Assets | — | 0.66 Cr | 0.96 Cr | 1.26 Cr | 1.35 Cr |
| Accumulated Depreciation | — | -1.25 Cr | -0.77 Cr | -0.66 Cr | -0.84 Cr |
| Machinery Furniture Equipment | — | 3.12 Cr | 0.84 Cr | 0.48 Cr | 0.61 Cr |
| Buildings And Improvements | — | 0.38 Cr | 0.38 Cr | 0.38 Cr | 0.38 Cr |
| Land And Improvements | — | 0.27 Cr | 0.27 Cr | 0.27 Cr | 0.27 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 26.71 Cr | 8.32 Cr | 11.41 Cr | 9.24 Cr |
| Raw Materials | — | 8.68 Cr | 29.08 Cr | 34.16 Cr | 35.14 Cr |
| Taxes Receivable | — | 4.16 Cr | 1.01 Cr | 0.05 Cr | 21000.00 |
| Gross Accounts Receivable | — | 39.45 Cr | 8.19 Cr | 15.00 Cr | 15.42 Cr |
| Retained Earnings | — | — | 6.56 Cr | 5.76 Cr | 4.96 Cr |
| Additional Paid In Capital | — | — | 13.37 Cr | 13.37 Cr | 13.37 Cr |
| Allowance For Doubtful Accounts Receivable | — | — | 0.00 | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Chandra Bhagat Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.